Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the Treatment of Adult Upper Limb Spasticity .

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a phase III clinical study to evaluate the efficacy and safety of recombinant botulinum toxin type A(Eveotox)in adult patients with upper limb spasticity. The purpose of this study was to observe efficacy and safety of Eveotox compared with placebo in adult patients with upper limb spasticity.
Epistemonikos ID: 414cc2fb9331096117430cb830503eef516b2b24
First added on: Nov 22, 2025